Home The Word Brain	My Amedeo FAQ Privacy About
	CC Journal Club Our weekly journal club for junior residents and medical students

Prostate Cancer

Free Subscription 17.03.2025 1 AJR Am J Roentgenol 1 BMC Cancer 1 Cancer Imaging 1 Clin Cancer Res 1 Eur J Radiol 1 Eur Radiol 2 Eur Urol 2 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 2 J Nucl Med 1 JAMA 1 Magn Reson Imaging 1 Magn Reson Med 3 Prostate 1 Radiol Imaging Cancer 2 Radiology 1 Ther Adv Urol 3 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. SPILSETH B
   Moving Towards Widespread Adoption of Prostate Cancer Screening With MRI: Questions Remaining for Optimization.
   AJR Am J Roentgenol. 2025 Mar 12. doi: 10.2214/AJR.25.32892.
   PubMed        
   
   

   
   BMC Cancer

2. HUANG H, Wang T, Li W, Wu Z, et al
   Safety and efficacy of genomic biomarker-guided neoadjuvant therapy for locally advanced and oligometastatic prostate cancer (SEGNO): study protocol for an open-label prospective phase II umbrella clinical trial.
   BMC Cancer. 2025;25:432.
   PubMed         Abstract available
   
   

   
   Cancer Imaging

3. POROES F, Karampa P, Sartoretti T, Najberg H, et al
   Additional findings in prostate MRI.
   Cancer Imaging. 2025;25:29.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

4. ZHANG L, Teng PC, Cavassani KA, Wang J, et al
   Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity that Associates with a Clinically Aggressive Subtype of Prostate Cancer.
   Clin Cancer Res. 2025 Mar 10. doi: 10.1158/1078-0432.CCR-24-3660.
   PubMed         Abstract available
   
   

   
   Eur J Radiol

5. PAUSCH AM, Elsner C, Rupp NJ, Eberli D, et al
   Comparative analysis of TARGET and PI-FAB scores in mpMRI surveillance after HIFU therapy for localized prostate cancer.
   Eur J Radiol. 2025;186:112028.
   PubMed         Abstract available
   
   

   
   Eur Radiol

6. PADHANI AR, Papanikolaou N
   AI and human interactions in prostate cancer diagnosis using MRI.
   Eur Radiol. 2025 Mar 7. doi: 10.1007/s00330-025-11498.
   PubMed         Abstract available
   
   

   
   Eur Urol

7. HAGE CHEHADE C, Ozay ZI, Ostrowski M, Mercinelli C, et al
   T-cell Engagers in Prostate Cancer.
   Eur Urol. 2025 Mar 11:S0302-2838(25)00070-3. doi: 10.1016/j.eururo.2025.
   PubMed         Abstract available
   
   
8. DEVOS G, Giesen A, Joniau S
   When Less Is More: The Challenges of Defining Residual Disease Following Neoadjuvant Hormonal Therapy in Prostate Cancer.
   Eur Urol. 2025 Mar 10:S0302-2838(25)00146-0. doi: 10.1016/j.eururo.2025.
   PubMed        
   
   

   
   Int J Radiat Oncol Biol Phys

9. PATEL P, Dreibe S, Attard G, Cole A, et al
   Stereotactic body radiotherapy for oligoprogressive disease in androgen suppressed prostate cancer: Primary endpoint analysis of the TRAP trial.
   Int J Radiat Oncol Biol Phys. 2025 Mar 9:S0360-3016(25)00225.
   PubMed         Abstract available
   
   
10. VENKATESULU BP, Adams W, Joel R, Ross D, et al
    The Importance of Multi-parametric MRI, PET/CT, and Biopsy for Identifying and Delineating the Extent of Intraprostatic Radiorecurrent Prostate Cancer: A Secondary Analysis of the F-SHARP Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2025 Mar 6:S0360-3016(25)00193.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

11. SLOVIN SF
    Immune Checkpoint Combos in Metastatic Castration-Resistant Prostate Cancer: Where Are We Going, What Are We Doing, and Why?
    J Clin Oncol. 2025 Mar 13:JCO2402402. doi: 10.1200/JCO-24-02402.
    PubMed        
    
    

    
    J Nucl Med

12. BERNER K, Hernes E, Kvassheim M, Revheim ME, et al
    First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted (212)Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer.
    J Nucl Med. 2025 Mar 13:jnumed.124.269299. doi: 10.2967/jnumed.124.269299.
    PubMed         Abstract available
    
    
13. JEWELL KE, Buteau JP, Medhurst E, Kwan EM, et al
    Safety and Efficacy of 20 Cycles of [(177)Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
    J Nucl Med. 2025 Mar 13:jnumed.124.269447. doi: 10.2967/jnumed.124.269447.
    PubMed        
    
    

    
    JAMA

14. RAYCHAUDHURI R, Lin DW, Montgomery RB
    Prostate Cancer: A Review.
    JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.0228.
    PubMed         Abstract available
    
    

    
    Magn Reson Imaging

15. BOSCHHEIDGEN M, Drewes L, Valentin B, Ullrich T, et al
    Use of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admission.
    Magn Reson Imaging. 2025 Feb 10:110358. doi: 10.1016/j.mri.2025.110358.
    PubMed         Abstract available
    
    

    
    Magn Reson Med

16. MA X, Seres P, Kinnaird A, Fung C, et al
    Diffusion time effects over the adult lifespan indicates persistent zone-specific microstructural alterations in the human prostate with aging.
    Magn Reson Med. 2025;93:2059-2069.
    PubMed         Abstract available
    
    

    
    Prostate

17. VIGANO S, Finati M, Stephens A, Bertini A, et al
    Socioeconomic Disparities in Prostate Cancer Treatment: The Impact of Area Deprivation Index on Initial Treatment Type for Localized PCa in a North-American Cohort.
    Prostate. 2025 Mar 11:e24882. doi: 10.1002/pros.24882.
    PubMed         Abstract available
    
    
18. ONAL C, Guler OC, Erbay G, Demirhan B, et al
    Propensity Score Matched Analysis of External Beam Radiotherapy With or Without Focal Boost to Intraprostatic Lesions in Prostate Cancer.
    Prostate. 2025 Mar 11. doi: 10.1002/pros.24888.
    PubMed         Abstract available
    
    
19. MONDIA MWL, Batchala PP, Dreicer R, Devitt ME, et al
    Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review.
    Prostate. 2025 Mar 13. doi: 10.1002/pros.24890.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

20. MATTAY GS
    A New Challenge in Prostate Cancer: Assessing Discrepant Results from Prostate MRI and PSMA PET/CT.
    Radiol Imaging Cancer. 2025;7:e259007.
    PubMed        
    
    

    
    Radiology

21. LEE YJ, Moon HW, Choi MH, Eun Jung S, et al
    MRI-based Deep Learning Algorithm for Assisting Clinically Significant Prostate Cancer Detection: A Bicenter Prospective Study.
    Radiology. 2025;314:e232788.
    PubMed         Abstract available
    
    
22. TAKAHASHI T
    Prostate Cancer Screening: Empirical Clinical Practice for 70 Years.
    Radiology. 2025;314:e242184.
    PubMed        
    
    

    
    Ther Adv Urol

23. MATRONE F, Urso L, Girometti R, Polesel J, et al
    The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est).
    Ther Adv Urol. 2025;17:17562872251321971.
    PubMed         Abstract available
    
    

    
    Urology

24. BOCHNER E, Johnson B, Franzen B, Hertz A, et al
    Artificial Urinary Sphincter Placement Before or After Radiation Therapy: Does Timing of Radiation Impact Surgical Complications and Continence?
    Urology. 2025;197:185-189.
    PubMed         Abstract available
    
    
25. BRODSKY CN, Daignault-Newton S, Davenport MS, Marchetti KA, et al
    How Many Cores Should Be Collected per Region of Interest in Fusion Targeted Prostate Biopsy? A Retrospective Single Institution Statistical Simulation.
    Urology. 2025;197:133-140.
    PubMed         Abstract available
    
    
26. PICKERSGILL NA, Alkazemi MH, Ostergar A, Joseph K, et al
    Correlation of Prostate High-Resolution Microultrasound With Multiparametric Magnetic Resonance Imaging.
    Urology. 2025;197:33-39.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.